DEVON, Pa., Nov. 09, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will participate at various upcoming investor meetings and conferences.
, Chairman and CEO, will present at the Jefferies London Healthcare Conference in London, UK, on November 17, 2016 at 2:00 pm GMT.
, CFO and VP Corporate Development, will present at the Stifel 2016 Healthcare Conference in New York City on November 16, 2016 at 1:30 pm ET. Mr. Fickenscher will be joined by Donna Gutterman
, PharmD, VP Medical, in participation at the Maxim Group Central Nervous Disease Conference in New York City on November 17, 2016.
To listen to a webcast of the Jefferies or Stifel presentations live, please visit the Investor Relations page